The Norwegian Research Council’s commitment to commercialization of research – FORNY, has awarded three research projects at the University of Bergen (UiB) a total of 15 million NOK. The funding will make the research teams able to test their concepts in the market together with Bergen Teknologioverføring (BTO).
In total BTO sent 20 applications to NFR earlier this autumn and 11 were granted. BTO applied for both FORNY main project funding and milestone funding. In total, BTO will receive 18,5 million NOK in funding for the 11 projects we work on together with our owners and research partners. This is a good result as the national competition for FORNY funding is very hard, and the total amount of funding available is 87 million NOK
–We are proud that 11 projects will receive funding. These are all great projects from some of the outstanding scientist we work with. The projects have great potential and will provide new and better solutions for society if we succeed. I would like to thank NFR for the trust they put in us and we look forward to deliver, says Anders Haugland, Managing director of BTO.
The three projects that have been granted FORNY main project funding is:
IGC – Environmental-friendly defrost
How to find a transparent and environmentally friendly material that prevents the formation of ice and dew? Dr. Naureen Akthar, together with Professor Bodil Holst, has made a whole new material. It shows record high performance compared to today’s solutions and has a wide range of applications by preventing ice on instruments and instruments without destroying material or environment.
Along with leading players in aviation, optics and materials technology, measures will be taken to make the project more technologically and commercially mature for the market. The Research Council of Norway has supported the project from an early stage.
3D printing parts of your skeleton
3D printing of polymeric bone-like structures can give patients suffering from complex fractures of bones to have opportunities to live an optimal life, in the aftermath of the damage/accident . Kamal Babikeir Eln Mustafa has led a research group in the last ten years who has come up with a solution that uses the not only the scaffolds but also in combination with patient’s own stem cells. The solution has the potential to help millions of people around the world to significantly improve their life quality.
In the next phase, the project will now focus on testing the technology, in order to ensure preclinical data.
Algal toxin without opioids
Neosaxitoxin is an algal toxin found in mussels, oysters and scallops. Clinical trials show that this natural product can be used as an anesthetic after surgery. This means that strong painkillers and addictive drugs such as morphine can be replaced with agents that have far more beneficial effects on the health of individuals. The challenge with neosaxitoxin is that there is no scalable production method. Through research conducted by Dr Ralf Kellmann, a scalable biological production process was developed that could cover the future needs of neosaxitoxin in the world. Socially, this could potentially have a huge gain, as many today become highly dependent on existing drugs, both in Norway and in the world otherwise.
With FORNY funds, the research group will now take the step further to verify that the new production process is sustainable in an industrial setting.
About the program- FORNY 2020
The main objective of the program is increased commercial use of promising research results from publicly funded research institutions in Norway. The program prioritizes projects with high expected commercial and social returns and high implementation capacity.
The ideas and research results are generated by researchers and students from higher education institutions in Norway. Source: forskningsradet.no